Antimicrobial resistance mechanisms among campylobacter

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wieczorek, Kinga ^a   Osek, Jacek ^a  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; NALIDIXIC ACID; QUINOLONE DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; GENE MUTATION; GENE TARGETING; HUMAN; NONHUMAN; REVIEW; SEQUENCE HOMOLOGY; ANIMAL; CAMPYLOBACTER INFECTIONS; DRUG EFFECTS; MICROBIOLOGY; DRUG EFFECT;

ANIMALS; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; MACROLIDES;

EID: 84880162902     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/340605     Document Type: Review

References (131)

1. Blaser B., Engberg J., Nachamkin I., Szymanski C. M., Blaser M. J., Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. Campylobacter 2008 Washington, DC, USA American Society for Microbiology 99 121
2. Allos B. M., Campylobacter jejuni infections: update on emerging issues and trends. Clinical Infectious Diseases 2001 32 8 1201 1206 2-s2.0-0035870985 10.1086/319760
3. Ruiz-Palacios G. M., The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clinical Infectious Diseases 2007 44 5 701 703 2-s2.0-33847082547 10.1086/509936
4. Huang D. B., Musher D., Musher B. L., Contagious acute gastrointestinal infections. The New England Journal of Medicine 2005 352 12 1267 1268 2-s2.0-15444371988 10.1056/NEJM200503243521221
5. Robinson D. A., Infective dose of Campylobacter jejuni in milk. British Medical Journal 1981 282 6276 1584 2-s2.0-0006789181
6. Tribble D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., Guerry P., Larsson C. J., Rockabrand D., Ventone C. H., Poly F., Lyon C. E., Dakdouk S., Fingar A., Gilliland T. Jr., Daunais P., Jones E., Rymarchyk S., Huston C., Darsley M., Kirkpatrick B. D., Campylobacter jejuni strain CG8421: a refined model for the study of campylobacteriosis and evaluation of campylobacter vaccines in human subjects. Clinical Infectious Diseases 2009 49 10 1512 1519 2-s2.0-72849112054 10.1086/644622
7. Black R. E., Levine M. M., Clements M. L., Hughes T. P., Blaser M. J., Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988 157 3 472 479 2-s2.0-0023931412
8. Calva J. J., Ruiz-Palacios G. M., Lopez-Vidal A. B., Ramos A., Bojalil R., Cohort study of intestinal infection with campylobacter in Mexican children. The Lancet 1988 1 8584 503 506 2-s2.0-0023870696
9. McCarthy N., Giesecke J., Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. American Journal of Epidemiology 2001 153 6 610 614 2-s2.0-0035869570 10.1093/aje/153.6.610
10. Tam C. C., Rodrigues L. C., Petersen I., Islam A., Hayward A., O'Brien S. J., Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. Journal of Infectious Diseases 2006 194 1 95 97 2-s2.0-33745188039 10.1086/504294
11. Pope J. E., Krizova A., Garg A. X., Thiessen-Philbrook H., Ouimet J. M., Campylobacter reactive arthritis: a systematic review. Seminars in Arthritis and Rheumatism 2007 37 1 48 55 2-s2.0-34447649411 10.1016/j.semarthrit.2006.12.006
12. Isenbarger D. W., Hoge C. W., Srijan A., Pitarangsi C., Vithayasai N., Bodhidatta L., Hickey K. W., Cam P. D., Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerging Infectious Diseases 2002 8 2 175 180 2-s2.0-0036192506
13. Nachamkin I., Ung H., Li M., Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerging Infectious Diseases 2002 8 12 1501 1503 2-s2.0-0036917942
14. Fitzgerald F., Whichard J., Nachamkin I., Nachamkin I., Szymanski C. M., Blaser M. J., Diagnosis and antimicrobial susceptibility of Campylobacter species. Campylobacter 2008 Washington, DC, USA American Society for Microbiology 227 243
15. Fliegelman R. M., Petrak R. M., Goodman L. J., Segreti J., Trenholme G. M., Kaplan R. L., Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrobial Agents and Chemotherapy 1985 27 3 429 430 2-s2.0-0021962142
16. Vanhoof R., Goossens H., Coignau H., Stas G., Butzler J. P., Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrobial Agents and Chemotherapy 1982 21 6 990 992 2-s2.0-0019915815
17. McNulty C. A. M., The treatment of campylobacter infections in man. Journal of Antimicrobial Chemotherapy 1987 19 3 281 284 2-s2.0-0023145324
18. Jacoby G. A., Mechanisms of resistance to quinolones. Clinical Infectious Diseases 2005 41 supplement 2 S120 S126 2-s2.0-21844477302
19. Charvalos E., Peteinaki E., Spyridaki I., Manetas S., Tselentis Y., Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. Journal of Clinical Laboratory Analysis 1996 10 3 129 133
20. Payot S., Avrain L., Magras C., Praud K., Cloeckaert A., Chaslus-Dancla E., Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. International Journal of Antimicrobial Agents 2004 23 5 468 472 2-s2.0-2342652248 10.1016/j.ijantimicag.2003.12.008
21. Payot S., Bolla J.-M., Corcoran D., Fanning S., Mégraud F., Zhang Q., Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes and Infection 2006 8 7 1967 1971 2-s2.0-33746631314 10.1016/j.micinf.2005.12.032
22. Engberg J., Aarestrup F. M., Taylor D. E., Gerner-Smidt P., Nachamkin I., Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases 2001 7 1 24 34 2-s2.0-0035108778
23. Aarestrup F. M., Engberg J., Antimicrobial resistance of thermophilic Campylobacter. Veterinary Research 2001 32 3-4 311 321 2-s2.0-0034960155
24. Ge B. L., McDermott P. F., White D. G., Meng J. H., Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 2005 49 8 3347 3354 2-s2.0-23044512221 10.1128/AAC.49.8.3347-3354.2005
25. Wang Y., Wai Mun Huang W. M. H., Taylor D. E., Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy 1993 37 3 457 463 2-s2.0-0027471287
26. Lin J., Overbye Michel L., Zhang Q. J., CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2002 46 7 2124 2131 2-s2.0-0036635124 10.1128/AAC.46.7.2124-2131.2002
27. Pumbwe L., Piddock L. J. V., Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiology Letters 2002 206 2 185 189 2-s2.0-0037050288 10.1016/S0378-1097(01) 00532-8
28. Luo N., Sahin O., Lin J., Michel L. O., Zhang Q., In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrobial Agents and Chemotherapy 2003 47 1 390 394 2-s2.0-12244305604 10.1128/AAC.47.1.390-394.2003
29. Pumbwe L., Randall L. P., Woodward M. J., Piddock L. J. V., Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. Journal of Antimicrobial Chemotherapy 2004 54 2 341 347 2-s2.0-4444336144 10.1093/jac/dkh331
30. Pumbwe L., Randall L. P., Woodward M. J., Piddock L. J. V., Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF. Antimicrobial Agents and Chemotherapy 2005 49 4 1289 1293 2-s2.0-16244387902 10.1128/AAC.49.4.1289-1293.2005
31. Akiba M., Lin J., Barton Y.-W., Zhang Q. J., Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. Journal of Antimicrobial Chemotherapy 2006 57 1 52 60 2-s2.0-30344434342 10.1093/jac/dki419
32. Endtz H. P., Ruijs G. J., Van Klingeren B., Jansen W. H., Van der Reyden T., Mouton R. P., Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. Journal of Antimicrobial Chemotherapy 1991 27 2 199 208 2-s2.0-0026011978
33. Khachatourians G. G., Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria. Canadian Medical Association Journal 1998 159 9 1129 1136 2-s2.0-0031726155
34. McDermott P. F., Bodeis S. M., English L. L., White D. G., Walker R. D., Zhao S., Simjee S., Wagner D. D., Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. Journal of Infectious Diseases 2002 185 6 837 840 2-s2.0-0037086424 10.1086/339195
35. van Boven M., Veldman K. T., de Jong M. C. M., Mevius D. J., Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. Journal of Antimicrobial Chemotherapy 2003 52 4 719 723 2-s2.0-0141928519 10.1093/jac/dkg402
36. Griggs D. J., Johnson M. M., Frost J. A., Humphrey T., Jørgensen F., Piddock L. J. V., Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrobial Agents and Chemotherapy 2005 49 2 699 707 2-s2.0-12944335169 10.1128/AAC.49.2.699-707.2005
37. Humphrey T. J., Jørgensen F., Frost J. A., Wadda H., Domingue G., Elviss N. C., Griggs D. J., Piddock L. J. V., Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrobial Agents and Chemotherapy 2005 49 2 690 698 2-s2.0-12944300320 10.1128/AAC.49.2.690-698.2005
38. Connell S. R., Trieber C. A., Dinos G. P., Einfeldt E., Taylor D. E., Nierhaus K. H., Mechanism of Tet(O)-mediated tetracycline resistance. EMBO Journal 2003 22 4 945 953 2-s2.0-0037450699 10.1093/emboj/cdg093
39. Taylor D. E., Courvalin P., Mechanisms of antibiotic resistance in Campylobacter species. Antimicrobial Agents and Chemotherapy 1988 32 8 1107 1112 2-s2.0-0023788876
40. Taylor D. E., Garner R. S., Allan B. J., Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 1983 24 6 930 935 2-s2.0-0021051668
41. Chopra I., Roberts M., Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and Molecular Biology Reviews 2001 65 2 232 260 2-s2.0-0034973583 10.1128/MMBR.65.2.232-260.2001
42. Harms J. M., Bartels H., Schlünzen F., Yonath A., Antibiotics acting on the translational machinery. Journal of Cell Science 2003 116 8 1391 1393 2-s2.0-0038745414 10.1242/jcs.00365
43. Gibreel A., Tracz D. M., Nonaka L., Ngo T. M., Connell S. R., Taylor D. E., Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrobial Agents and Chemotherapy 2004 48 9 3442 3450 2-s2.0-4344619151 10.1128/AAC.48.9.3442-3450.2004
44. Connell S. R., Tracz D. M., Nierhaus K. H., Taylor D. E., Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrobial Agents and Chemotherapy 2003 47 12 3675 3681 2-s2.0-0344443255 10.1128/AAC.47.12.3675-3681.2003
45. Chopra I., Hlavka J. J., Boothe J. H., Mode of action of the tetracyclines and the nature of bacterial resistance to them. The Tetracyclines (Handbook of Experimental Pharmacology) 1985 Berlin, Germany Springer 317 392
46. Pratt A., Korolik V., Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates. Journal of Antimicrobial Chemotherapy 2005 55 4 452 460 2-s2.0-17444366610 10.1093/jac/dki040
47. Batchelor R. A., Pearson B. M., Friis L. M., Guerry P., Wells J. M., Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology 2004 150 10 3507 3517 2-s2.0-6444241113 10.1099/mic.0.27112-0
48. Poehlsgaard J., Douthwaite S., The bacterial ribosome as a target for antibiotics. Nature Reviews Microbiology 2005 3 11 870 881 2-s2.0-28144441826 10.1038/nrmicro1265
49. Yao J. D., Moellering R. Jr., Murray P. R., Baron E. J., Jorgensen J., Pfaller M. A., Yolken R. H., Antimicrobial agents. Manual of Clinical Microbiology 2003 Washington, DC, USA ASM Press 1047 1050
50. Pfister P., Jenni S., Poehlsgaard J., Thomas A., Douthwaite S., Ban N., Böttger E. C., The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23 S rRNA positions 2058 and 2059. Journal of Molecular Biology 2004 342 5 1569 1581 2-s2.0-4444300505 10.1016/j.jmb.2004.07.095
51. Fouts D. E., Mongodin E. F., Mandrell R. E., Miller W. G., Rasko D. A., Ravel J., Brinkac L. M., Deboy R. T., Parker C. T., Daugherty S. C., Dodson R. J., Scott Durkin A., Madupu R., Sullivan S. A., Shetty J. U., Ayodeji M. A., Shvartsbeyn A., Schatz M. C., Badger J. H., Fraser C. M., Nelson K. E., Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biology 2005 3 1, article e15 2-s2.0-20044387762 10.1371/journal.pbio.0030015
52. Jensen L. B., Aarestrup F. M., Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrobial Agents and Chemotherapy 2001 45 1 371 372 2-s2.0-0035172404 10.1128/AAC.45.1.371-372.2001
53. Guerry P., Yao R. J., Alm R. A., Burr D. H., Trust T. J., Systems of experimental genetics for Campylobacter species. Methods in Enzymology 1994 235 474 481 2-s2.0-0028198979 10.1016/0076-6879(94)35163-5
54. Jeon B., Muraoka W., Sahin O., Zhang Q., Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2008 52 8 2699 2708 2-s2.0-48749106037 10.1128/AAC.01607-07
55. Avrain L., Vernozy-Rozand C., Kempf I., Evidence for natural horizontal transfer of tetO gene between Campylobacter jejuni strains in chickens. Journal of Applied Microbiology 2004 97 1 134 140 2-s2.0-3042784810 10.1111/j.1365-2672. 2004.02306.x
56. Cagliero C., Mouline C., Cloeckaert A., Payot S., Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 2006 50 11 3893 3896 2-s2.0-33750577739 10.1128/AAC.00616-06
57. Caldwell D. B., Wang Y., Lin J., Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2008 52 11 3947 3954 2-s2.0-55849146664 10.1128/AAC.00450-08
58. Corcoran D., Quinn T., Cotter L., Fanning S., An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. International Journal of Antimicrobial Agents 2006 27 1 40 45 2-s2.0-29944443936 10.1016/j.ijantimicag.2005.08.019
59. Lin J., Yan M., Sahin O., Pereira S., Chang Y.-J., Zhang Q., Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrobial Agents and Chemotherapy 2007 51 5 1678 1686 2-s2.0-34248345414 10.1128/AAC.01411-06
60. Gibreel A., Wetsch N. M., Taylor D. E., Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2007 51 9 3212 3216 2-s2.0-35948957361 10.1128/AAC.01592-06
61. Cagliero C., Mouline C., Payot S., Cloeckaert A., Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. Journal of Antimicrobial Chemotherapy 2005 56 5 948 950 2-s2.0-27744597006 10.1093/jac/dki292
62. Cagliero C., Cloix L., Cloeckaert A., Payot S., High genetic variation in the multidrug transporter cmeB gene in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 2006 58 1 168 172 2-s2.0-33748066638 10.1093/jac/dkl212
63. Jana S., Deb J. K., Molecular understanding of aminoglycoside action and resistance. Applied Microbiology and Biotechnology 2006 70 2 140 150 2-s2.0-33644547013 10.1007/s00253-005-0279-0
64. Zhang Q., Plummer J., Nachamkin I., Szymanski C. M., Blaser M. J., Mechanism of antibiotic resistance in Campylobacter. Campylobacter 2008 Washington, DC, USA American Society for Microbiology 263 276
65. Llano-Sotelo B., Azucena E. F. Jr., Kotra L. P., Mobashery S., Chow C. S., Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chemistry & Biology 2002 9 4 455 463 2-s2.0-0036237683 10.1016/S1074-5521(02)00125-4
66. Engberg J., Keelan M., Gerner-Smidt P., Taylor D. E., Aarestrup F. M., Antimicrobial resistance in Campylobacter. Antimicrobial Resistance in Bacteria of Animal Origin 2006 Washingtond, DC, USA American Society for Microbiology 269 291
67. Taylor D. E., Yan W., Ng L.-K., Manavathu E. K., Courvalin P., Genetic characterization of kanamycin resistance in Campylobacter coli. Annales de l'Institut Pasteur Microbiology 1988 139 6 665 676 2-s2.0-0024242268
68. Tenover F. C., Fennell C. L., Lee L., LeBlanc D. J., Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant. Antimicrobial Agents and Chemotherapy 1992 36 4 712 716 2-s2.0-0026555567
69. Tenover F. C., Gilbert T., O'Hara P., Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid 1989 22 1 52 58 2-s2.0-0024419023
70. Lachance N., Gaudreau C., Lamothe F., Lariviere L. A., Role of the β -lactamase of Campylobacter jejuni in resistance to β -lactam agents. Antimicrobial Agents and Chemotherapy 1991 35 5 813 818 2-s2.0-0025847032
71. Reina J., Ros M. J., Serra A., Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrobial Agents and Chemotherapy 1994 38 12 2917 2920 2-s2.0-0028019460
72. Tajada P., Gomez-Garces J.-L., Alós J.-I., Balas D., Cogollos R., Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 β -lactam agents and combinations with β -lactamase inhibitors. Antimicrobial Agents and Chemotherapy 1996 40 8 1924 1925 2-s2.0-0029799754
73. Martin S. I., Kaye K. M., Beta-lactam antibiotics: newer formulations and newer agents. Infectious Disease Clinics of North America 2004 18 3 603 619 2-s2.0-4043066483 10.1016/j.idc.2004.04.006
74. Guordabssi L., Courvalin P., Aarestrup F. M., Modes of antimicrobial action and mechanisms of bacterial resistance. Antimicrobial Resistance in Bacteria of Animal Origin 2006 Washingtond, DC, USA American Society for Microbiology 269 291
75. Lin J., Akiba M., Sahin O., Zhang Q. J., CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2005 49 3 1067 1075 2-s2.0-14744279812 10.1128/AAC.49.3.1067-1075.2005
76. Lin J., Sahin O., Michel L. O., Zhang Q. J., Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infection and Immunity 2003 71 8 4250 4259 2-s2.0-0042265519 10.1128/IAI.71.8.4250-4259.2003
77. Luangtongkum T., Jeon B., Han J., Plummer P., Logue C. M., Zhang Q., Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiology 2009 4 2 189 200 2-s2.0-63849262661 10.2217/17460913.4.2. 189
78. Sykes R. B., Matthew M., The β lactamases of Gram negative bacteria and their role in resistance to β lactam antibiotics. Journal of Antimicrobial Chemotherapy 1976 2 2 115 157 2-s2.0-0017208308
79. Schlünzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., Franceschi F., Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001 413 6858 814 821 2-s2.0-0035950132 10.1038/35101544
80. Schwarz S., Kehrenberg C., Doublet B., Cloeckaert A., Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiology Reviews 2004 28 5 519 542 2-s2.0-6344291118 10.1016/j.femsre.2004.04.001
81. Wang Y., Taylor D. E., Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction. Gene 1990 94 1 23 28 2-s2.0-0025132642 10.1016/0378-1119(90)90463-2
82. Sam W. I. C., Lyons M. M., Waghorn D. J., Increasing rates of ciprofloxacin resistant campylobacter. Journal of Clinical Pathology 1999 52 9 709 2-s2.0-0032859738
83. Hart W. S., Heuzenroeder M. W., Barton M. D., Antimicrobial resistance in Campylobacter spp., Escherichia coli and enterococci associated with pigs in Australia. Journal of Veterinary Medicine B 2004 51 5 216 221 2-s2.0-4544290502 10.1111/j.1439-0450.2004.00760.x
84. Schönberg-Norio D., Hänninen M.-L., Katila M.-L., Kaukoranta S.-S., Koskela M., Eerola E., Uksila J., Pajarre S., Rautelin H., Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrobial Agents and Chemotherapy 2006 50 3 1086 1088 2-s2.0-33644654449 10.1128/AAC.50.3.1086-1088. 2006
85. Sjögren E., Lindblom G.-B., Kaijser B., Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. Journal of Antimicrobial Chemotherapy 1997 40 2 257 261 2-s2.0-1842378017 10.1093/jac/40.2.257
86. Skjøt-Rasmussen L., Ethelberg S., Emborg H.-D., Agersø Y., Larsen L. S., Nordentoft S., Olsen S. S., Ejlertsen T., Holt H., Nielsen E. M., Hammerum A. M., Trends in occurrence of antimicrobial resistance in Campylobacter jejuni isolates from broiler chickens, broiler chicken meat, and human domestically acquired cases and travel associated cases in Denmark. International Journal of Food Microbiology 2009 131 2-3 277 279 2-s2.0-64349108122 10.1016/j.ijfoodmicro.2009.03.006
87. Juntunen P., Heiska H., Olkkola S., Myllyniemi A.-L., Hänninen M.-L., Antimicrobial resistance in Campylobacter coli selected by tylosin treatment at a pig farm. Veterinary Microbiology 2010 146 1-2 90 97 2-s2.0-78049278287 10.1016/j.vetmic.2010.04.027
88. Hoge C. W., Gambel J. M., Srijan A., Pitarangsi C., Echeverria P., Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clinical Infectious Diseases 1998 26 2 341 345 2-s2.0-0031882666
89. Jain D., Sinha S., Prasad K. N., Pandey C. M., Campylobacter species and drug resistance in a north Indian rural community. Transactions of the Royal Society of Tropical Medicine and Hygiene 2005 99 3 207 214 2-s2.0-12144258953 10.1016/j.trstmh.2004.09.006
90. Qin S.-S., Wu C.-M., Wang Y., Jeon B., Shen Z.-Q., Wang Y., Zhang Q., Shen J.-Z., Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China. International Journal of Food Microbiology 2011 146 1 94 98 2-s2.0-79953064998 10.1016/j.ijfoodmicro.2011.01.035
91. Sonnevend Á., Rotimi V. O., Kolodziejek J., Usmani A., Nowotny N., Pál T., High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates. Journal of Medical Microbiology 2006 55 11 1533 1538 2-s2.0-33750822271 10.1099/jmm.0.46744-0
92. Bester L. A., Essack S. Y., Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa. Journal of Antimicrobial Chemotherapy 2008 62 6 1298 1300 2-s2.0-56649091420 10.1093/jac/dkn408
93. Ruiz J., Marco F., Oliveira I., Vila J., Gascón J., Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2007 115 3 218 224 2-s2.0-33947268751 10.1111/j.1600-0463.2007.apm-567.x
94. Woźniak A., Fluoroquinolones resistance of Campylobacter jejuni and Campylobacter coli isolated from poultry in 1994-1996 and 2005-2008 in Poland. Bulletin of the Veterinary Institute in Pulawy 2011 55 1 15 20 2-s2.0-79953052676
95. Luber P., Wagner J., Hahn H., Bartelt E., Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany. Antimicrobial Agents and Chemotherapy 2003 47 12 3825 3830 2-s2.0-0345306167 10.1128/AAC.47.12.3825-3830. 2003
96. Hariharan H., Sharma S., Chikweto A., Matthew V., DeAllie C., Antimicrobial drug resistance as determined by the E-test in Campylobacter jejuni, C. coli, and C. lari isolates from the ceca of broiler and layer chickens in Grenada. Comparative Immunology, Microbiology and Infectious Diseases 2009 32 1 21 28 2-s2.0-55949128309 10.1016/j.cimid.2008.01.010
97. Norström M., Johnsen G., Hofshagen M., Tharaldsen H., Kruse H., Antimicrobial resistance in Campylobacter jejuni from broilers and broiler house environments in Norway. Journal of Food Protection 2007 70 3 736 738 2-s2.0-33947366895
98. Rautelin H., Renkonen O.-V., Kosunen T. U., Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrobial Agents and Chemotherapy 1991 35 10 2065 2069 2-s2.0-0026014262
99. Hakanen A., Jousimies-Somer H., Siitonen A., Huovinen P., Kotilainent P., Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerging Infectious Diseases 2003 9 2 267 270 2-s2.0-0345074114
100. Huysmans M. B., Turnidge J. D., Disc susceptibility testing for thermophilic campylobacters. Pathology 1997 29 2 209 216 2-s2.0-0030871971 10.1080/00313029700169884
101. Unicomb L., Ferguson J., Riley T. V., Collignon P., Fluoroquinolone resistance in campylobacter absent from isolates, Australia. Emerging Infectious Diseases 2003 9 11 1482 1483 2-s2.0-0242386545
102. Adler-Mosca H., Luthy-Hottenstein J., Martinetti Lucchini G., Burnens A., Altwegg M., Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 1991 10 11 953 957 2-s2.0-0026341599
103. Ellis-Pegler R. B., Hyman L. K., Ingram R. J. H., McCarthy M., A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. Journal of Antimicrobial Chemotherapy 1995 36 1 259 263 2-s2.0-0029165056
104. Bae W., Kaya K. N., Hancock D. D., Call D. R., Park Y. H., Besser T. E., Prevalence and antimicrobial resistance of thermophilic Campylobacter spp. from cattle farms in Washington State. Applied and Environmental Microbiology 2005 71 1 169 174 2-s2.0-12244288344 10.1128/AEM.71.1.169-174.2005
105. Vlieghe E. R., Jacobs J. A., Van Esbroeck M., Koole O., Van Gompel A., Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni / Campylobacter coli isolates recovered from international travelers, 1994 to 2006. Journal of Travel Medicine 2008 15 6 419 425 2-s2.0-56849117901 10.1111/j.1708-8305.2008.00236.x
106. Chen X., Naren G.-W., Wu C.-M., Wang Y., Dai L., Xia L.-N., Luo P.-J., Zhang Q., Shen J.-Z., Prevalence and antimicrobial resistance of Campylobacter isolates in broilers from China. Veterinary Microbiology 2010 144 1-2 133 139 2-s2.0-77953776045 10.1016/j.vetmic.2009.12.035
107. Woźniak A., Wieliczko A., Tetracycline, erythromycin, and gentamicin resistance of Campylobacter jejuni and Campylobacter coli isolated from poultry in Poland. Bulletin of the Veterinary Institute in Pulawy 2011 55 1 51 54 2-s2.0-79953031684
108. Parkhill J., Wren B. W., Mungall K., Ketley J. M., Churcher C., Basham D., Chillingworth T., Davies R. M., Feltwell T., Holroyd S., Jagels K., Kartyshev A. V., Moule S., Pallen M. J., Penn C. W., Quail M. A., Rajandream M.-A., Rutherford K. M., Van Vliet A. H. M., Whitehead S., Barrell B. G., The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000 403 6770 665 668 2-s2.0-0034628526 10.1038/35001088
109. Zhang Q., Sahin O., McDermott P. F., Payot S., Fitness of antimicrobial-resistant Campylobacter and Salmonella. Microbes and Infection 2006 8 7 1972 1978 2-s2.0-33746614060 10.1016/j.micinf.2005.12.031
110. Wistrom J., Norrby S. R., Fluoroquinolones and bacterial enteritis, when and for whom? Journal of Antimicrobial Chemotherapy 1995 36 1 23 39 2-s2.0-0029101838
111. Aarestrup F. M., McDermott P. F., Wegener H. C., Nachamkin I., Szymanski C. M., Blaser M. J., Transmission of antibiotic resistance from food animals to humans. Campylobacter 2008 Washington, DC, USA American Society for Microbiology 645 665
112. Wilson D. L., Bell J. A., Young V. B., Wilder S. R., Mansfield L. S., Linz J. E., Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture. Microbiology 2003 149 12 3603 3615 2-s2.0-0346252342
113. de Boer P., Wagenaar J. A., Achterberg R. P., van Putten J. P. M., Schouls L. M., Duim B., Generation of Campylobacter jejuni genetic diversity in vivo. Molecular Microbiology 2002 44 2 351 359 2-s2.0-0036231382 10.1046/j.1365-2958.2002.02930.x
114. Bacon D. J., Alm R. A., Burr D. H., Hu L., Kopecko D. J., Ewing C. P., Trust T. J., Guerry P., Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infection and Immunity 2000 68 8 4384 4390 2-s2.0-0033942331 10.1128/IAI.68.8.4384-4390.2000
115. Tracz D. M., Keelan M., Ahmed-Bentley J., Gibreel A., Kowalewska-Grochowska K., Taylor D. E., pVir and bloody diarrhea in Campylobacter jejuni enteritis. Emerging Infectious Diseases 2005 11 6 838 843 2-s2.0-19344369674
116. Gibreel A., Sköld O., Taylor D. E., Characterization of plasmid-mediated aphA-3 kanamycin resistance in Campylobacter jejuni. Microbial Drug Resistance 2004 10 2 98 105 2-s2.0-3042729692 10.1089/1076629041310127
117. Velazquez J. B., Jimenez A., Chomon B., Villa T. G., Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 1995 35 1 173 178 2-s2.0-0028927791
118. Nirdnoy W., Mason C. J., Guerry P., Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2005 49 6 2454 2459 2-s2.0-19544364887 10.1128/AAC.49.6.2454-2459.2005
119. Kim J.-S., Carver D. K., Kathariou S., Natural transformation-mediated transfer of erythromycin resistance in Campylobacter coli strains from Turkeys and swine. Applied and Environmental Microbiology 2006 72 2 1316 1321 2-s2.0-33144460977 10.1128/AEM.72.2.1316-1321.2006
120. Lee M. D., Sanchez S., Zimmer M., Idris U., Berrang M. E., McDermott P. F., Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Antimicrobial Agents and Chemotherapy 2002 46 11 3660 3664 2-s2.0-0036839179 10.1128/AAC.46.11.3660-3664.2002
121. O'Halloran F., Lucey B., Cryan B., Buckley T., Fanning S., Molecular characterization of class 1 integrons from Irish thermophilic Campylobacter spp. Journal of Antimicrobial Chemotherapy 2004 53 6 952 957 2-s2.0-3042690063 10.1093/jac/dkh193
122. Yan M., Sahin O., Lin J., Zhang Q., Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. Journal of Antimicrobial Chemotherapy 2006 58 6 1154 1159 2-s2.0-33845353844 10.1093/jac/dkl412
123. Han J., Sahin O., Barton Y.-W., Zhang Q., Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni. PLoS Pathogens 2008 4 6 2-s2.0-46449110879 10.1371/journal.ppat.1000083 e1000083
124. Farnell M. B., Donoghue A. M., Cole K., Reyes-Herrera I., Blore P. J., Donoghue D. J., Campylobacter susceptibility to ciprofloxacin and corresponding fluoroquinolone concentrations within the gastrointestinal tracts of chickens. Journal of Applied Microbiology 2005 99 5 1043 1050 2-s2.0-27444440285 10.1111/j.1365-2672.2005.02712.x
125. Wretlind B., Stromberg A., Ostlund L., Sjogren E., Kaijser B., Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. Scandinavian Journal of Infectious Diseases 1992 24 5 685 686 2-s2.0-0026466854
126. Delsol A. A., Sunderland J., Woodward M. J., Pumbwe L., Piddock L. J. V., Roe J. M., Emergence of fluoroquinolone resistance in the native Campylobacter coli population of pigs exposed to enrofloxacin. Journal of Antimicrobial Chemotherapy 2004 53 5 872 874 2-s2.0-2442685484 10.1093/jac/dkh150
127. Gibreel A., Taylor D. E., Macrolide resistance in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 2006 58 2 243 255 2-s2.0-33748057492 10.1093/jac/dkl210
128. Gibreel A., Kos V. N., Keelan M., Trieber C. A., Levesque S., Michaud S., Taylor D. E., Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrobial Agents and Chemotherapy 2005 49 7 2753 2759 2-s2.0-21444449865 10.1128/AAC.49.7.2753-2759.2005
129. Inglis G. D., McAllister T. A., Busz H. W., Yanke L. J., Morck D. W., Olson M. E., Read R. R., Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis. Applied and Environmental Microbiology 2005 71 7 3872 3881 2-s2.0-22144473350 10.1128/AEM.71.7.3872-3881.2005
130. Pacanowski J., Lalande V., Lacombe K., Boudraa C., Lesprit P., Legrand P., Trystram D., Kassis N., Arlet G., Mainardi J.-L., Doucet-Populaire F., Girard P.-M., Meynard J.-L., Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clinical Infectious Diseases 2008 47 6 790 796 2-s2.0-51549090963 10.1086/591530
131. Engberg J., Neimann J., Nielsen E. M., Aarestrup F. M., Fussing V., Quinolone-resistant Campylobacter infections in Denmark: risk factors and clinical consequences. Emerging Infectious Diseases 2004 10 6 1056 1063 2-s2.0-2542513998